RT Journal Article
SR Electronic
T1 Landmark-based analysis of speech differentiates conversational from clear speech in speakers with muscle tension dysphonia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.20.22281337
DO 10.1101/2022.10.20.22281337
A1 Ishikawa, Keiko
A1 Pietrowicz, Mary
A1 Charney, Sara
A1 Orbelo, Diana
YR 2022
UL http://medrxiv.org/content/early/2022/10/21/2022.10.20.22281337.abstract
AB This study evaluated the feasibility of differentiating conversational and clear speech produced by individuals with muscle tension dysphonia (MTD) using Landmark-Based Analysis of Speech (LMBAS). Thirty-four adult speakers with MTD recorded conversational and clear speech. Of those, 27 speakers were able to produce clear speech. The recordings of these individuals were analyzed with an open-source LMBAS program, SpeechMark®, MATLAB Toolbox ver. 1.1.2.The mixed-effect logistic regression model indicated that the burst-onset landmark differentiated conversational speech from clear speech. The LMBAS is a potential approach for detecting the difference between conversational and clear speech in individuals with mild to moderate MTD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Mayo Clinic Alix School of Medicine gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.